CI Global Healthcare Leaders Index ETF

CBOE CANADA TICKER : CHCL.B
 

Fund overview

CHCL seeks to replicate, to the extent reasonably possible, the performance of a global healthcare index, net of expenses. Currently, CHCL seeks to replicate the performance of the Solactive Developed Markets Healthcare 150 CAD Index (CA NTR). The Index intends to track the performance of the largest 150 companies from the global healthcareindustry.

Fund details

description of elementelement value
Inception date August 2021
Total net assets ($CAD)
As at 2024-07-24
$266.9 million
NAVPS
As at 2024-07-24
$23.7797
Market price
As at 2024-07-24
$22.8900
MER (%)
As at 2023-12-31
0.38
Management fee (%) 0.35
Units outstanding
As at 2024-07-24
11,225,000
Asset class Sector Equity
Currency CAD
CUSIP 12567E109
Distribution frequency Quarterly
Last distribution $0.1157

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

Investor suitability

For those who:
  • want exposure to the largest 150 companies from the global healthcare industry
  • are investing for the medium and/or long term
  • can tolerate medium risk

Performance2 As at 2024-06-30

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
11.96% 2.26% 1.58% 11.96% 14.38% - - - 6.45%
*Since inception date

Distribution history3

Payable date Total
2024-06-24 0.1157
2024-03-21 0.0281
2023-12-20 0.1000
2023-09-22 0.0541
2023-06-23 0.0587
Payable date Total
2023-03-24 0.0283
2022-12-21 0.0250
2022-09-22 0.0780
2022-06-23 0.2570
2022-03-24 0.0299

Management team

First we'll display the Team Company and then the Team members
Lijon Geeverghese

CI Global Healthcare Leaders Index ETF

CBOE CANADA TICKER : CHCL.B
 
Portfolio allocations4 As at 2024-06-30
Asset allocation (%)
  • US Equity 69.80
  • International Equity 30.22
  • Cash and Equivalents 0.06
  • Other -0.08
Sector allocation (%)
  • Healthcare 96.28
  • Consumer Services 1.44
  • Consumer Goods 1.05
  • Industrial Goods 0.46
  • Financial Services 0.38
  • Other 0.33
  • Cash and Cash Equivalent 0.06
Geographic allocation(%)
  • United States 69.58
  • Switzerland 6.99
  • Denmark 6.30
  • United Kingdom 4.22
  • Japan 4.04
  • Other 2.23
  • France 2.19
  • Ireland 1.67
  • Australia 1.54
  • Germany 1.24
Top holdings
Sector (%)
1. Eli Lilly and Co Drugs 9.66%
2. UnitedHealth Group Inc Healthcare Services 5.96%
3. Novo Nordisk A/S Cl B Drugs 5.79%
4. Johnson & Johnson Drugs 4.44%
5. Merck & Co Inc Drugs 3.96%
6. AbbVie Inc Drugs 3.82%
7. AstraZeneca PLC Drugs 2.95%
8. Thermo Fisher Scientific Inc Healthcare Equipment 2.69%
9. Novartis AG Cl N Drugs 2.57%
10. Roche Holding AG - Partcptn Drugs 2.46%
11. Abbott Laboratories Healthcare Equipment 2.27%
12. Amgen Inc Drugs 2.10%
13. Danaher Corp Healthcare Equipment 2.08%
14. Pfizer Inc Drugs 1.99%
15. Intuitive Surgical Inc Healthcare Equipment 1.96%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.